Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery

ClinicalTrials.gov ID: NCT00404014

Public ClinicalTrials.gov record NCT00404014. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study Designed to Evaluate the Safety, Tolerability, and Effect of a Single, Rising Dose of Intravenous AL-208, Followed by a Placebo-Controlled, Double-Blind, Parallel-Group Evaluation of a Single Dose of AL-208, on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to compare mild cognitive impairment in the AL-208 group with the placebo group at 14 + - 3 days after CABG surgery

Study identification

NCT ID
NCT00404014
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allon Therapeutics
Industry
Enrollment
234 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2006 (Type not available)
Primary completion
Jun 2008 (Actual)
Completion
Jun 2008 (Actual)
Last update posted
Oct 24, 2012

2006 – 2008

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Physicians Clinical Research Corp. Laguna Hills California 92653 —
Sacramento Heart and Vascular Research Center Sacramento California 95825 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Miami Research Associates South Miami Florida 33143 —
Piedmont Hospital Research Institute Atlanta Georgia 30309 —
The Atlanta Heart and Vascular Research Group Atlanta Georgia 30342 —
Rush University Medical Center Chicago Illinois 60612 —
Chicago Heart Institute and Vein Clinic Elk Grove Village Illinois 60007 —
Illinois Heart and Vascular Foundation Hindsdale Illinois 60521 —
Indiana/Ohio Heart Cardiothoracic and Vascular Surgeons Fort Wayne Indiana 46804 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Cardiothoracic Associates Flint Michigan 48532 —
NYU Medical Center New York New York 10016 —
Duke University Medical Center Durham North Carolina 27710 —
Carolina Cardiovascular Surgical Associates, PA Raleigh North Carolina 27610 —
Memory Assessment and Research Services Wilmington North Carolina 28405 —
St. Vincent Mary Medical Center Toledo Ohio 43608 —
Tulsa Clinical Resesarch, LLC Tulsa Oklahoma 74104-5428 —
Consultants in Cardiovascular Diseases Inc. Erie Pennsylvania 16502 —
Clinical Research Solutions, PC Knoxville Tennessee 37920 —
Vanderbilt University Nashville Tennessee 37212 —
Clinical Cardiovascular Research Center Dallas Texas 75226 —
St. Luke's Episcopal Hospital Houston Texas 77030 —
Inova Fairfax Hospital Falls Church Virginia 22042 —
Cardiac and Thoracic Surgical Associates, Ltd. Mechanicsville Virginia 23116 —
Multicare Health Systems Tacoma Washington 98415 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00404014, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2012 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00404014 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →